Otros idiomas Lepu Biopharma Co., Ltd.

Acciones

2157

CNE100004SM4

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:08:20 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
5,04 ^HKD	+7,23 %		+16,94 %	+19,71 %

12/04	Keymed Biosciences avanza en un fármaco para tumores sólidos con el estudio del primer paciente	MT
27/03	Lepu Biopharma Co. Ltd. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Keymed Biosciences Advances Solid Tumors Drug With First Patient Study	12/04
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Lepu Biopharma's Pancreatic Cancer Drug Gets US FDA Fast-Track Designation	11/03
Lepu Biopharma Co., Ltd. Receives Fast Track Designation by the Food and Drug Administration of the United States for the Treatment of Pancreatic Cancer	11/03
Lepu Biopharma Shareholders to Vote Jan. 31 on Contract to Produce Drugs for Lepu Medical Technology	17/01
Lepu Biopharma Co., Ltd. Announces Completion of Patient Enrollment of Pivotal Phase IIb Clinical Trial for MRG003 for the Treatment of R/M NPC	28/12
Lepu Biopharma Completes Patient Enrollment for Phase 2B Trial for Nasopharyngeal Cancer Drug	29/12
Lepu Biopharma Renews Procurement Agreement With Lepu Medical Technology	26/12
Lepu Biopharma Gets US FDA's Orphan Drug Designation for Pancreatic Cancer Drug	14/12
Lepu Biopharma Co., Ltd. Announces Orphan-Drug Designation Granted by the FDA to MRG004A for the Treatment of Pancreatic Cancer	14/12
US FDA Grants Fast Track Designation to Lepu Biopharma's Anti-Cancer Drug	04/12
Lepu Biopharma to Provide Drug Production Services to Lepu Medical Technology	14/11
Lepu Biopharma Divests 15% Stake in Technical Services Provider	29/09/23
China Medical System Holdings Limited entered into the equity transfer agreement to acquire 15% stake in Hangzhou HealSun Biopharm Co., Ltd. from Lepu Biopharma Co., Ltd. for approximately CNY 130 million.	29/09/23
Lepu Biopharma Co., Ltd.(SEHK:2157) added to S&P Global BMI Index	18/09/23
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Lepu Biopharma Seeks to Extend Validity of Secondary Listing in Shanghai	09/08/23
Stocks add to rebound; SSE ups earnings guidance	30/03/23
AstraZeneca Completes KYM Solid Tumors Treatment Deal	30/03/23
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/03/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Lepu Biopharma Co., Ltd.

Acciones

2157

CNE100004SM4

Otros idiomas

Filtros